Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 1-9 , 2 January 2004

The relationship between immune-mediated Type 1 diabetes mellitus and ethnicity

Received 24 September 2002 ,Accepted 1 November 2002.

References 

  1. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Reviews. 1994;15(4):516–542
  2. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1990;322:1836–1841
  3. Balducci-Silano PL, Layrisse Z, Domı́nguez E, Amaro R, Gunczler P, Lanes R, et al. HLA-DQA1 and DQB1 allele and genotype contribution to IDDM susceptibility in an ethnically mixed population. European Journal of Immunogenetics. 1994;21(6):405–414
  4. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human antigen DR3 and DR4: flatbush diabetes. Diabetes. 1994;43(6):741–745
  5. Bonifacio E, Christie MR. Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus. Annals of Medicine. 1997;29:405–412
  6. Chueca M, Oyarzabal M, Reparaz F, Garagorri JM, Sola A. Incidence of type 1 diabetes mellitus in Navarre, Spain (1975–91). Acta Paediatrica. 1997;86:632–637
  7. Cruickshanks KJ, Jobim LF, Lawler-Heavner J, Neville TG, Gay EC, Chase HP, et al. Ethnic differences in human leukocyte antigen markers of susceptibility to IDDM. Diabetes Care. 1994;17(2):132–137
  8. Dotta F, Di Mario U. Antigenic determinants in Type 1 diabetes mellitus. APMIS. 1996;104:769–774
  9. Elamin A, Omer MI, Zein K, Tuverno T. Epidemiology of childhood type 1 diabetes in Sudan, 1987–90. Diabetes Care. 1992;15:1556–1559
  10. Erlich H, Mack SJ, Bergström T, Gyllestein UB. HLA class II alleles in Amerindian populations: implications for the evolution of HLA polymorphism and the colonization of the Americas. Hereditas. 1997;127:19–24
  11. Erlich H, Rotter JI, Chang JD, Shaw S, Raffel LJ, Klitz W, et al. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes. 1996;45:610–614
  12. Erlich HA, Zeidler A, Chang J, Shaw S, Raffel LJ, Klitz W, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nature Genetics. 1993;3(4):358–364
  13. Fernández-Viña M, Morales JR, Morales ME, Miller S, Stastny P. HLA class II haplotypes in Amerindians and in black North and South Americans. Tissue Antigens. 1991;38(5):235–237
  14. Fernández-Viña M, Ramı́rez LC, Raskin P, Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans. Tissue Antigens. 1993;41:57–64
  15. Frazer de Lladó TE, González de Pijem L, Hawk B. The Puerto Rican IDDM Coalition: incidence of IDDM in children living in Puerto Rico. Diabetes Care. 1998;21(5):744–746
  16. Froguel P. Genetics of type 1 insulin-dependent diabetes mellitus. Hormone Research. 1997;48(Suppl. 4):55–57
  17. Goday A, Castell C, Tresserras R, Canela J, Taberner JL, Lloveras G  Catalan Epidemiology Diabetes Study Group . Incidence of type 1 (insulin-dependent) diabetes mellitus in Catalonia, Spain. Diabetologia. 1992;35:267–271
  18. Goday A, Motana E, Ercilla G, Fernández J, Gomis R, Vilardell E. HLA antigens in Spanish type 1 diabetic patient population. Correlations with clinical, biological and autoimmune markers. Acta Diabetologica Latina. 1990;27(3):215–222
  19. Gorodezky C, Olivo A, Alaez C, Vaázquez MN, de la Rosa G, Debaz H, et al. Secuencias moleculares de alto y bajo riesgo en enfermedades autoinmunes. Un análisis de la diabetes tipo 1 en Latinoamérica. Gaceta de México. 1997;133(1):125–132
  20. Greenbaum CJ, Palmer JP. Insulin antibodies and insulin autoantibodies. Diabetic Medicine. 1991;8:97–105
  21. Gutiérrez-López MD, Bertera S, Chantres MT, Vavasorri C, Dorman JS, Trucco M, et al. Susceptibility to type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQα Arg 52 and HLA-DQβ non-Asp 57 alleles. Diabetologia. 1992;35:583–588
  22. Harrison LC. Islet cell antibodies: light at the end of the tube?. Diabetes Care. 1994;17(10):1220–1222
  23. Hoover ML, Marta RT. Molecular modelling of HLA-DQ suggests a mechanism of resistance in type 1 diabetes. Scandinavian Journal of Immunology. 1997;45:193–202
  24. Huang W, She JX, Muir A, Laskowska D, Zorovich B, Schatz D, et al. High-risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies, but DQB1*0602 does not prevent them. Journal of Autoimmunity. 1994;7(6):889–897
  25. Knip M. Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. Annals of Medicine. 1997;29:447–451
  26. Kobayashi T, Oka Y, Katagiri H, Falorni A, Kasuga A, Takei I, et al. Association between HLA and islet cell antibodies in diabetic patients with mitochondrial DNA mutation at base pair 3243. Diabetologia. 1996;39:1196–1200
  27. Kostraba JN, Cruickshanks KJ, Neville TG, Lawler-Heavner J, Chase HP, Klingensmith GJ, et al. Clinical characteristics of IDDM in Hispanics and non-Hispanic whites: little evidence of heterogeneity by ethnicity. Diabetes Care. 1992;15(10):1303–1309
  28. Leech NJ, Kitabchi AE, Gaur LK, Hagopian WA, Hansen J, Burghen GA, et al. Genetic and immunological markers of insulin-dependent diabetes in Black Americans. Autoimmunity. 1995;22(1):27–32
  29. Lipman TH. Epidemiology of Type 1 diabetes in children 0–14 years of age in Philadelphia. Diabetes Care. 1993;16:923–925
  30. Lipton R, Laporte RE. Epidemiology of islet cell antibodies. Epidemiologic Reviews. 1989;11:182–203
  31. Lipton RB, Fivecoate J. High risk of IDDM in African-American and Hispanic children in Chicago, 1985–1990. Diabetes Care. 1995;18:476–482
  32. Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, et al. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives. Journal of Autoimmunity. 1999;12(4):279–287
  33. Mijovic CH, Barnete AH, Todd JA. Trans-racial gene mapping studies. Baillière's Clinical Endocrinology and Metabolism. 1991;5(2):321–340
  34. Morales P, Martı́nez-Laso J, Martı́n-Villa JM, Corell A, Vicario JL, Varela P, et al. High-frequency of the HLA DRB1*0405-(Dw15)-DQw8 haplotype in Spaniards and its relationship to diabetes susceptibility. Human Immunology. 1991;32(3):170–175
  35. Neufeld M, Maclaren NK, Riley WJ, Lezotte D, McLaughlin JV, Silverstein J, et al. Islet cell and other organ-specific antibodies in US Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes. 1980;29:589–592
  36. Oexle K, Oberle J, Finckh B, Kohlschüutter A, Nagy M, Seibel P, et al. Islet cell antibodies in diabetes mellitus associated with a mitochondrial tRNA Leu(UUR) gene mutation. Experimental and Clinical Endocrinology and Diabetes. 1996;104:212–217
  37. Omar MAK, Botazzo GF, Asmal AC. Islet cell autoantibodies and other autoantibodies in South African Blacks and Indians with insulin-dependent diabetes mellitus (IDDM). Hormone and Metabolic Research. 1986;18:126–128
  38. Pérez-Bravo F, Serrano-Rı́os M, Gutiérrez-López MD, Calvilláan M, Garcı́a de los Rı́os M, Kocova M, et al. Genetic analysis of HLA DRB1, DQA1 and DQB1 alleles and susceptibility to IDDM in Chilean subjects. Chile IDDM Study Group (letter). Diabetologia. 1995;38(3):378–379
  39. Pugliese A, Gianani R, Moromisato R, Awdeh ZL, Alper CA, Erlich HA, et al. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes. 1995;44:608–613
  40. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 1996;39:807–812
  41. Seidel D, Ziegler A-G. Prediction of Type 1 diabetes. Hormone Research. 1996;45(Suppl. 1):36–39
  42. Serjeantson SW, Easteal S. Cross-ethnic group comparisons of HLA class II alleles and insulin-dependent diabetes mellitus. Baillières Clinical Endocrinology and Metabolism. 1991;5(2):299–320
  43. Serrano-Rı́os M, Moy CS, Martı́n Serrano R, Minuesa Asensio A, de Tomas Labat ME, Zarandieta Romero G, et al. Incidence of type 1 (insulin-dependent) diabetes mellitus in subjects 0–14 years of age in the Comunidad de Madrid, Spain. Diabetologia. 1990;33:422–424
  44. Setién Baranda F, Coto E, Menéndez Dı́az J, Martı́nez Naves E, Alvarez Martı́nez V, López-Larrea C. HLA class II and susceptibility and resistance to insulin-dependent diabetes mellitus in a population from the Northwest of Spain. European Journal of Immunogenetics. 1994;21:219–239
  45. She J-X. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunology Today. 1996;17(7):323–329
  46. Spielman RS, Baur MP, Clerget-Darpoux F. Genetic analysis of IDDM: summary of GAW5 IDDM results. General Epidemiology. 1989;6:43–58
  47. Thai A-C, Eisenbarth GS. Natural history of IDDM. Diabetes Reviews. 1993;1(1):1–14
  48. Thorsby E, Gjertsen HA, Lundin KEA, Rønningen KS. Insulin dependent diabetes mellitus susceptibility or protection may be determined by certain HLA-DQ molecules. Baillières Clinical Endocrinology and Metabolism. 1991;5(3):361–373
  49. Van der Auwera B, Van Waeyenberge C, Schuit F, Heimberg H, Vandewalle C, Gorus F, et al. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301–DQB1*0302/DQA1*0501–DQB1*0201 genotype. Diabetes. 1995;44:608–613
  50. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with HLA DQA1*0301–DQB1*0302 haplotypes at clinical onset of Type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia. 1993;36:1155–1162
  51. Vicario JL, Martı́nez-Laso J, Corell A, Martı́n-Villa JM, Morales P, Lledo G, et al. Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as Type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population. Diabetologia. 1992;35:475–481
  52. Yasunaga S, Kimura A, Hamaguchi K, Rønningen KS, Sasazuki T. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens. 1996;47(1):37–48

PII: S1056-8727(02)00252-0

doi: 10.1016/S1056-8727(02)00252-0

Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 1-9 , 2 January 2004

Article Tools

* Image Usage & Resolution